MYB64 Antibody

What is MYB64 and why is it important in plant developmental research?

MYB64 is a MYB-family transcription factor that plays a crucial role in plant reproductive development. It acts as a transcriptional activator that specifically recognizes DNA sequences. In Arabidopsis, MYB64 functions redundantly with MYB119 to promote the FG5 transition during female gametophyte development. This transition marks the switch between free nuclear divisions and cellularization-differentiation processes .

MYB64 is particularly important because:

• It regulates the formation of cell walls (cellularization) during female gametophyte development

• It contributes to proper cell differentiation and establishment of gametophytic polarity

• It works in coordination with two-component signaling pathways involving the histidine kinase CKI1

• Mutations in both MYB64 and MYB119 result in uncellularized gametophytes with supernumerary nuclei

Understanding MYB64 provides critical insights into plant reproduction processes and transcriptional regulation of developmental transitions.

What are the optimal sample preparation techniques for MYB64 antibody applications?

When preparing samples for MYB64 antibody applications, researchers should consider:

Fixation and Preservation:

• For immunohistochemistry and immunofluorescence: Use 4% paraformaldehyde fixation for 24-48 hours, followed by paraffin embedding for plant reproductive tissues

• For protein extraction: Flash-freeze tissue samples in liquid nitrogen immediately after collection and store at -80°C

Protein Extraction Protocol:

• Grind tissue samples in liquid nitrogen to a fine powder

• Extract proteins using a buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100

  • 1 mM EDTA

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if studying phosphorylated forms)

• Centrifuge at 12,000g for 15 minutes at 4°C

• Collect supernatant and quantify protein concentration using Bradford assay

Fresh lysates should be used to minimize protein degradation, as seen with other MYB proteins . For immunoprecipitation experiments, additional care must be taken to preserve protein-protein interactions by adjusting detergent concentrations.

How can I validate the specificity of a MYB64 antibody?

Validating antibody specificity is crucial for obtaining reliable results. For MYB64 antibodies, consider these validation approaches:

Primary Validation Methods:

• Western blot with positive and negative controls

  • Positive control: Extract from tissues known to express MYB64 (female gametophytes at stage FG4-FG5)

  • Negative control: Extract from myb64 knockout mutant plants

  • Expected band size: Verify against predicted molecular weight (~72 kDa for MYB proteins)

• Peptide competition assay

  • Pre-incubate the antibody with the immunogenic peptide used to generate it

  • Run parallel western blots with treated and untreated antibody

  • Specific binding should be blocked in the peptide-treated sample

• Genetic validation

  • Test antibody against wild-type and myb64 mutant tissues

  • Signal should be absent or significantly reduced in mutant samples

• Phosphatase treatment

  • If working with phospho-specific antibodies, treat samples with phosphatase

  • Signal should be reduced after treatment

Secondary Validation:

• Immunofluorescence pattern should match previously reported MYB64-GFP expression patterns

• Cross-reactivity with related proteins (especially MYB119) should be assessed due to their sequence similarity

What expression patterns should I expect when using MYB64 antibodies in plant reproductive tissues?

Based on studies using MYB64-GFP fusion proteins, researchers should expect the following expression patterns:

Temporal Expression Pattern:

• First detected at stage FG4 (four-nucleate stage) of female gametophyte development

• Expression continues through stages FG5 and FG6

• Significantly reduced in mature female gametophytes (stage FG7)

Spatial Expression Pattern:

• Initially detected in all four nuclei of the female gametophyte at stage FG4

• Post-cellularization (FG5-FG6):

  • Strong expression in the central cell

  • Expression in the egg cell nucleus

  • Not detected in antipodal cells or synergid cells when using translational fusions

• Transcriptional fusions show broader expression in all cells of the female gametophyte

Additional Expression Sites:

• Expression also detected in the septum of the ovary

This distinctive expression pattern serves as a useful marker for validating antibody specificity and for studying developmental transitions in the female gametophyte.

How can MYB64 antibodies be used to investigate cell differentiation and polarity in female gametophytes?

MYB64 antibodies provide powerful tools for investigating the molecular mechanisms underlying cell differentiation and polarity establishment:

Experimental Approaches:

• Co-immunostaining with cell-specific markers

  • Combine MYB64 antibody with markers for specific female gametophyte cells:

    • Synergid cells: ProDD31:GFP

    • Egg cell: ProDD45:GFP

    • Central cell: ProDD65:GFP

    • Antipodal cells: ProDD1:GFP

  • This approach reveals the relationship between MYB64 expression and cell fate specification

• Chromatin immunoprecipitation (ChIP) analysis

  • Use MYB64 antibodies to identify direct target genes involved in:

    • Cell wall formation

    • Cell polarity establishment

    • Cell differentiation pathways

• Temporal analysis during development

  • Perform time-course immunostaining to track MYB64 localization relative to:

    • Nuclear migration events

    • Cellularization processes

    • Expression of polarity markers

Expected Results and Interpretation:
Based on myb64 myb119 double mutant phenotypes, we would expect MYB64 antibody staining to correlate with:

• The establishment of micropylar-chalazal polarity

• The differentiation of specific cell types, particularly at the micropylar end

• The timing of cellularization events

The absence of MYB64 and MYB119 results in expanded chalazal cell identity at the expense of micropylar cell identity, suggesting these factors promote micropylar cell fate specification.

What methodological considerations are important when performing ChIP-seq with MYB64 antibodies?

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) with MYB64 antibodies requires special considerations for successful execution:

Sample Preparation and Fixation:

• Harvest female reproductive tissues at precise developmental stages (FG4-FG6)

• Cross-link with 1% formaldehyde for 10 minutes at room temperature

• Quench with 0.125 M glycine

• Flash-freeze in liquid nitrogen

ChIP Protocol Optimization:

• Chromatin Fragmentation:

  • Sonicate to achieve fragments of 200-500 bp

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation:

  • Use 2-5 μg of MYB64 antibody per reaction

  • Include IgG control and input samples

  • Incubate overnight at 4°C with rotation

• Washing Conditions:

  • Use stringent washing to reduce background

  • Include high-salt washes to reduce non-specific binding

Data Analysis Considerations:

• Look for enrichment of MYB consensus binding sequences (5'-YAAC[GT]G-3') in peaks

• Compare with MYB119 ChIP-seq data to identify shared and unique targets

• Validate key targets with ChIP-qPCR using multiple primer sets

Potential Challenges:

• Limited tissue availability requiring pooling of samples

• Low nuclear abundance of MYB64 at certain stages

• Cross-reactivity with related MYB transcription factors

How can MYB64 antibodies be used to investigate the relationship between MYB64 and the CKI1-dependent two-component signaling pathway?

The interaction between MYB64 and the CKI1-dependent two-component signaling (TCS) pathway represents an important area of research. MYB64 antibodies can be utilized to explore this relationship through:

Co-immunoprecipitation (Co-IP) Studies:

• Immunoprecipitate MYB64 using anti-MYB64 antibodies

• Probe for TCS components in the precipitated complex

• Perform reverse Co-IP with antibodies against TCS components

• Analyze samples by western blotting or mass spectrometry

Phosphorylation Status Analysis:

• Use phospho-specific antibodies (similar to the approach for c-Myb phospho S11)

• Compare MYB64 phosphorylation in wild-type and cki1 mutant backgrounds

• Analyze changes in phosphorylation following manipulation of TCS pathway activity

Comparative Expression Analysis:

• Perform immunohistochemistry for MYB64 in:

  • Wild-type plants

  • cki1 mutants

  • TCS reporter lines

• Compare timing and localization of MYB64 expression relative to TCS activation

Based on previous research, we know that MYB119 expression is regulated by CKI1, while MYB64 appears to function independently . This differential regulation allows MYB64 to compensate for the loss of MYB119 in cki1 mutants, making it a critical factor in the regulatory network controlling female gametophyte development.

What are the optimal conditions for western blot analysis using MYB64 antibodies?

Western blot analysis with MYB64 antibodies requires careful optimization to ensure specific detection:

Sample Preparation:

• Extract proteins using the protocol described in section 1.2

• Use fresh lysates to minimize degradation

• Include phosphatase inhibitors to preserve phosphorylation status

Gel Electrophoresis Parameters:

• Use 8-10% SDS-PAGE for optimal separation

• Load 10-20 μg of total protein per lane

• Include molecular weight markers to identify the expected band (~72 kDa for MYB proteins)

Transfer and Blocking Conditions:

• Transfer to PVDF membrane at 100V for 1 hour or 30V overnight at 4°C

• Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

Antibody Incubation:

• Primary antibody (MYB64): 1:1000 to 1:2000 dilution, overnight at 4°C

• Secondary antibody (HRP-conjugated): 1:5000 dilution, 1 hour at room temperature

Signal Detection and Troubleshooting:

• Use enhanced chemiluminescence (ECL) for detection

• Expected band size: 72-77 kDa (based on other MYB proteins)

• Multiple bands may represent:

  • Phosphorylated forms

  • Splice variants

  • Degradation products

• Verify specificity using peptide competition assays as described in section 1.3

How can I optimize immunohistochemistry protocols for detecting MYB64 in plant reproductive tissues?

Immunohistochemistry (IHC) for MYB64 in plant reproductive tissues requires specialized approaches:

Tissue Preparation:

• Fix ovules in 4% paraformaldehyde in PBS for 24 hours at 4°C

• Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%)

• Clear with xylene and embed in paraffin

• Section at 5-8 μm thickness

• Mount on positively charged slides

Antigen Retrieval Methods:

• Heat-mediated antigen retrieval with citrate buffer (pH 6.0) is recommended

• Boil sections for 10-20 minutes followed by cooling to room temperature

Staining Protocol:

• Deparaffinize and rehydrate sections

• Perform antigen retrieval

• Block endogenous peroxidase with 3% H₂O₂ (if using HRP-based detection)

• Block with 5% normal serum in PBS + 0.1% Triton X-100 for 1 hour

• Incubate with primary antibody (1:100 to 1:200) overnight at 4°C

• Wash 3x with PBS

• Incubate with biotinylated secondary antibody for 1 hour at room temperature

• Wash 3x with PBS

• Apply detection reagent (HRP-streptavidin or fluorophore-conjugated secondary)

• Counterstain, dehydrate, and mount

Controls and Validation:

• Positive control: Tissues known to express MYB64 (female gametophytes at stages FG4-FG6)

• Negative control: Primary antibody omission

• Specificity control: Pre-adsorption with immunogenic peptide

• Genetic control: myb64 mutant tissues

What approaches can be used to detect post-translational modifications of MYB64 using antibodies?

Post-translational modifications (PTMs) of MYB64 likely play important roles in regulating its activity. Based on research with related MYB proteins, several approaches can be used to detect PTMs:

Phosphorylation Analysis:

• Phospho-specific antibodies:

  • Generate antibodies against predicted phosphorylation sites

  • Validate using phosphatase treatment (similar to approaches used for c-Myb phospho S11)

  • Compare patterns before and after treatment with kinase inhibitors

• 2D gel electrophoresis:

  • First dimension: Isoelectric focusing to separate based on charge

  • Second dimension: SDS-PAGE to separate based on size

  • Detect MYB64 using standard antibodies

  • Multiple spots indicate different phosphorylation states

Other PTM Detection Methods:

• Ubiquitination: Immunoprecipitate MYB64 and probe with anti-ubiquitin antibodies

• SUMOylation: Immunoprecipitate MYB64 and probe with anti-SUMO antibodies

• Acetylation: Use acetylation-specific antibodies or mass spectrometry analysis

Mass Spectrometry Approach:

• Immunoprecipitate MYB64 using validated antibodies

• Digest with trypsin

• Analyze by LC-MS/MS

• Search for peptides with modifications

• Quantify relative abundance of modified peptides

This approach can provide comprehensive mapping of multiple PTMs simultaneously, offering insights into the complex regulation of MYB64 activity.

What are the key considerations for generating new MYB64-specific antibodies?

When generating new antibodies against MYB64, researchers should consider:

Antigen Design Strategy:

• Peptide Selection:

  • Choose unique regions that differ from MYB119 and other MYB family members

  • Target N- or C-terminal regions that typically have lower conservation

  • Consider accessibility (avoid hydrophobic regions)

  • Optimal peptide length: 10-20 amino acids

• Recombinant Protein Approach:

  • Express full-length or domain-specific MYB64

  • Use bacterial or insect cell systems for protein production

  • Purify under denaturing or native conditions depending on intended use

Immunization and Production:

• Choose between polyclonal and monoclonal approaches:

Validation Requirements:

• Test against both wild-type and myb64 mutant samples

• Perform peptide competition assays

• Check cross-reactivity with MYB119 and other MYB proteins

• Validate in multiple assays (western blot, IHC, immunoprecipitation)

• Sequence verification of the MYB64 gene in your experimental system

Application-Specific Considerations:

• For ChIP applications, select antibodies that recognize native, non-denatured protein

• For western blot, antibodies recognizing denatured epitopes may be sufficient

• For co-immunoprecipitation, avoid antibodies targeting protein-protein interaction domains

How does antibody selection differ when studying MYB64 across different plant species?

When extending MYB64 research to different plant species, antibody selection becomes critical:

Cross-Reactivity Assessment:

• Perform sequence alignment of MYB64 across target species

• Identify conserved and variable regions

• Select antibodies targeting highly conserved epitopes for cross-species applications

• For species-specific studies, target divergent regions

Validation in New Species:

• Test antibody against protein extracts from the new species

• Include appropriate positive and negative controls

• Confirm specificity using overexpression or knockdown approaches in the target species

• Verify expression patterns against published transcriptomic data

Considerations for Major Crop Plants:

• For monocots (rice, maize, wheat): MYB protein structure may differ significantly

• For dicots closely related to Arabidopsis: Higher probability of cross-reactivity

• For gymnosperms and lower plants: May require completely new antibody development

A recommended approach is to test commercial antibodies against conserved epitopes first, then proceed to custom antibody development if necessary, targeting species-specific regions of MYB64.

What are the most effective approaches for quantifying MYB64 protein levels throughout development?

Accurate quantification of MYB64 protein levels is essential for understanding its developmental regulation:

Western Blot Quantification:

• Use gradient loading of samples to ensure linearity of signal

• Include recombinant MYB64 protein standards at known concentrations

• Normalize to multiple loading controls (actin, GAPDH, histone H3)

• Use fluorescent secondary antibodies for wider linear range

• Analyze using densitometry software with background subtraction

ELISA-Based Quantification:

• Develop sandwich ELISA using two different MYB64 antibodies

• Standard curve with recombinant protein

• Higher throughput than western blot

• More sensitive for low abundance samples

Mass Spectrometry Approaches:

• Selected Reaction Monitoring (SRM) or Multiple Reaction Monitoring (MRM)

• Absolute quantification using isotope-labeled reference peptides

• Allows simultaneous measurement of multiple MYB family members

Developmental Time Course Analysis:
Based on MYB64-GFP studies, concentrate analysis on:

• Stage FG4 (first detection)

• Stages FG5-FG6 (peak expression)

• Stage FG7 (reduced expression)

This precise temporal regulation suggests MYB64 functions primarily during the critical FG5 transition period.

How can I resolve inconsistent results when using MYB64 antibodies in different applications?

Inconsistent results across different applications often stem from distinct requirements for protein conformation and epitope accessibility:

Systematic Troubleshooting Approach:

• Epitope Accessibility Issues:

  • For fixed tissues: Test different fixation methods (paraformaldehyde vs. glutaraldehyde)

  • For western blots: Compare reducing vs. non-reducing conditions

  • For immunoprecipitation: Use less stringent lysis buffers to preserve native structure

• Antibody Concentration Optimization:

  • Perform titration experiments for each application

  • Typical ranges:

    • Western blot: 1:500-1:5000

    • IHC/IF: 1:50-1:500

    • ChIP: 2-5 μg per reaction

    • IP: 1-10 μg per reaction

• Buffer Compatibility:

  • Test different blocking agents (BSA, normal serum, commercial blockers)

  • Optimize detergent concentrations (0.05-0.3% Triton X-100 or Tween-20)

  • Adjust salt concentrations (150-500 mM NaCl)

Application-Specific Remedies:

Antibody Storage and Handling:

• Avoid repeated freeze-thaw cycles

• Store antibody aliquots at -20°C

• For working solutions, store at 4°C with preservatives

• Check for precipitation before use

How can I distinguish between MYB64 and closely related MYB transcription factors in my experiments?

Distinguishing MYB64 from closely related factors, particularly MYB119, requires careful experimental design:

Antibody Selection Strategies:

• Epitope mapping:

  • Identify unique regions in MYB64 not present in MYB119

  • Generate antibodies against these specific regions

  • Validate using recombinant MYB64 and MYB119 proteins

• Cross-adsorption techniques:

  • Pre-adsorb antibodies with recombinant MYB119 protein

  • This removes antibodies that cross-react with both proteins

  • The remaining antibodies should be specific to MYB64

Genetic Approaches to Validate Specificity:

• Test in wild-type, myb64 single mutant, and myb64 myb119 double mutant backgrounds

• The signal should be present in wild-type, absent in the double mutant, and reduced in the single mutant

Molecular Weight Differentiation:

• MYB64 and MYB119 may have slightly different molecular weights

• Use high-resolution SDS-PAGE (8-10% gels) for better separation

• Consider using 2D gel electrophoresis to separate based on both size and charge

Expression Pattern Comparison:
Based on the research data, MYB64 and MYB119 have overlapping but distinct expression patterns:

• Both are expressed in female gametophytes at stages FG4-FG6

• MYB64 is detected in egg cell nuclei, while MYB119 is not

• MYB64-GFP is weakly detected in 26% of mature gametophytes, while MYB119-GFP is not detectable at this stage

These expression differences can help confirm antibody specificity in immunofluorescence experiments.